Make your complex medicine here with confidence.

November 20, 2025

Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy

Press Release . Biomanufacturing . Drug Product . Sterile Fill/Finish . In The News . Financing

November 20, 2025

Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian

Cell Therapy . Technology . Resources

October 29, 2025

Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy

Press Release . Biomanufacturing . Drug Product . Sterile Fill/Finish . In The News . Financing

July 11, 2025

How integrated data systems enhance clinical development and manufacturing

Biomanufacturing . Tech Transfer . Technology . Development

June 27, 2025

CDMOs Are Making Their Supply Chains More Resilient & Secure

Biomanufacturing . In The News . Development

June 05, 2025

Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead

Biomanufacturing . Drug Product

May 08, 2025

On Demand Webinar:  Fill/Finish Services - Outsourced Pharma Capacity Update

Biomanufacturing . Drug Product . Sterile Fill/Finish . Webinar

May 06, 2025

Cell Therapy Innovations: Reducing Costs to Improve Patient Access

Cell Therapy . Biomanufacturing

March 28, 2025

Executive Interview: Advancing Therapies That Transform Lives

Company Culture

March 26, 2025

Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash

Press Release . Biomanufacturing . Drug Product . In The News . Partnerships

January 30, 2025

Presentation: Rapid Multi-Omics Cell Therapy Characterization and QC

Cell Therapy . Technology . Presentation . Resources

January 29, 2025

Whitepaper: 3-Day Short Cycle CAR-T Manufacturing Process

Cell Therapy . Technology . White Paper . Resources

January 15, 2025

Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy

Press Release . In The News . Media Coverage

January 14, 2025

Presentation: Expedited Cell Therapy QC: Sample in, to QC Report in 48 Hours 

Cell Therapy . Technology . Presentation . Resources

January 08, 2025

Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD

Press Release . In The News . Media Coverage

December 05, 2024

Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive Officer

Press Release . Company Culture . In The News . Media Coverage

November 05, 2024

On-Demand Webinar: Outsourced Pharma Capacity Update - Drug Substance

Biologics . Facilities . Webinar . Presentation . Drug Substance

October 28, 2024

Key Steps in the Vaccine Scale-up Journey

Vaccines . Regulatory

October 03, 2024

Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients

Press Release . Biomanufacturing . In The News . Media Coverage . Government/NGO

September 30, 2024

Resilience Appoints Dr. Susan Billings, Chief Commercial Officer

Press Release . Company Culture . In The News . Media Coverage

July 10, 2024

Boston, MA: Process & Analytical Development and Manufacturing Facility

Vaccines . Biologics . Facilities . Gene Therapy . Process and Analytical Development . Resources

July 01, 2024

On-Demand Webinar: Outsourced Pharma Capacity Update - Fill/Finish

Drug Product . Sterile Fill/Finish

June 27, 2024

On-Demand Presentation: Improving cell line development in CHO with a focus on product manufacturability

Biologics . Presentation . Resources

June 27, 2024

Meet the Team: Viral Vector Development & Manufacturing

Gene Therapy . Biomanufacturing . Tech Transfer . Company Culture . Process and Analytical Development

June 05, 2024

Alachua Campus Tour Video

Government/NGO

May 02, 2024

Revised Annex 1 and the Focus on Microbial Control Strategies

Biomanufacturing . Drug Product . Regulatory . Sterile Fill/Finish . Resources

April 25, 2024

Starburst Data Rebel Awards: Data Product of the Year

In The News . Awards . Technology

March 25, 2024

Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space

Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish . Resources

March 07, 2024

On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules

Vaccines . Biologics . Facilities . Biomanufacturing . Drug Product . Tech Transfer . Process and Analytical Development

February 23, 2024

On-demand Webinar: Optimize research and delivery of complex medicines using data insights

Webinar . Partnerships . Technology

February 20, 2024

Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities

Press Release . In The News . Partnerships

February 19, 2024

Scale Your Vaccine Development with Path-to-PAD

Vaccines . Process and Analytical Development

February 13, 2024

How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines

Company Culture

February 05, 2024

National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation

Press Release . In The News . Partnerships

January 11, 2024

Successful Development and Manufacturing of Vaccines Containing Aluminum Adjuvants

Vaccines . Sterile Fill/Finish

January 04, 2024

Developing New Medicines Through Artificial Intelligence

Technology . Artificial Intelligence . Protein-Engineering

January 04, 2024

Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Press Release . In The News

December 21, 2023

The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing

Tech Transfer . Technology . White Paper . Resources

December 20, 2023

Resilience builds lab supply chain tracking platform on AWS

Biomanufacturing . Partnerships . Technology

December 12, 2023

On-demand Video: Efficiency Meets Economy: The Power of Single-Use Chromatography in mAb Purification

Biologics

December 11, 2023

Resilience Announces Expansion in West Chester

Press Release . In The News . Partnerships

November 30, 2023

How digital twins help improve biomanufacturing quality and security

Digital Twins . Technology

November 17, 2023

On-demand Video: Idea to Clinic – Aim to Reduce your Manufacturing Timeline by ~30%

Biologics . Biomanufacturing

November 07, 2023

Resilience Appoints Bill Marth as President of Services

Press Release . Partnerships

October 26, 2023

Accelerating Clinical Timelines of Induced Pluripotent Stem Cells (iPSCs) with Pluristyx

Cell Therapy . Biomanufacturing . In The News . Partnerships

October 03, 2023

BridgeBio and Resilience Announce Strategic Multi-Year Partnership

Press Release . Partnerships

August 29, 2023

The Challenges and Solutions for Viral Products

Vaccines . Biomanufacturing

August 28, 2023

How Early-Phase Companies Can Future-Proof Their Cell Therapies

Cell Therapy . Process and Analytical Development

August 28, 2023

Resilience Announces Joint Venture with Lifera in Saudi Arabia

Press Release . Partnerships

July 13, 2023

Opening of Resilience's West Coast Cell Therapy PAD Center

Cell Therapy . Biomanufacturing . In The News

July 12, 2023

On-Demand Webinar: High-Throughput Process & Analytical Platforms to Accelerate Gene Therapy Scale-Up

Gene Therapy . Process and Analytical Development

July 05, 2023

Overcoming Obstacles in Gene Therapy Manufacturing

Gene Therapy . Biomanufacturing

May 23, 2023

On-Demand Webinar: Future-Proof Your Aseptic Filling

Webinar

May 16, 2023

Resilience Enters Into Strategic Collaboration with Labcorp to Accelerate Cell and Gene Therapies

Cell Therapy . Gene Therapy . Biomanufacturing

May 11, 2023

Problem Solving for Aseptic Filling

Drug Product . Sterile Fill/Finish

May 08, 2023

On Demand Webinar: Outsourced Pharma Capacity Update-Large Molecules

Vaccines . Biologics . Facilities . Biomanufacturing . Drug Product . Tech Transfer . Process and Analytical Development

May 04, 2023

Leveraging Partnerships to Achieve Cell Therapy Success

Cell Therapy . Biomanufacturing

April 03, 2023

Master Cell Banks: Laying the Foundation to Final Product Success

Gene Therapy . Biomanufacturing

March 24, 2023

Resilience Approved For $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity

Press Release . Financing

March 23, 2023

Looking Ahead: What Does the Future Have in Store for Nucleic Acid-Based Therapies?

Nucleic Acids

February 16, 2023

Resilience Signs Multi-Year Strategic Biomanufacturing Partnership With Leading Pharmaceutical Company

Press Release

January 25, 2023

Alachua Biomanufacturing Expansion Video

Vaccines . Biologics . Gene Therapy . Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish

January 10, 2023

Resilience Announces Equity Investment From Mubadala And Funding Of New Biopharma Manufacturing Facility In The United Arab Emirates

Press Release

January 03, 2023

Resilience to Establish Biomanufacturing Partnership with AstraZeneca and Purchase Manufacturing Site

Vaccines . Biologics . Biomanufacturing . Sterile Fill/Finish

November 29, 2022

Cell Therapy – What Does It Take To Become a Mainstream Option

Cell Therapy . Biomanufacturing . Resources

November 29, 2022

On Demand Drug Substance Manufacturing and Drug Product Fill/Finish Solutions Presentation

Biologics . Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish . Process and Analytical Development . Webinar

November 29, 2022

Resilience To Establish A Biomanufacturing Partnership With AstraZeneca And Purchase AstraZeneca’s Manufacturing Site In West Chester, Ohio

Press Release

October 12, 2022

National Resilience Honored By Goldman Sachs For Entrepreneurship

Press Release

October 05, 2022

On-Demand Webinar: Establishing a Stage-Gate Approach to Biomanufacturing

Webinar

August 23, 2022

Resilience Becomes Biomanufacturing Resource Partner For California Institute For Regenerative Medicine

Press Release

August 15, 2022

Resilience Announces Collaboration To Manufacture And Deliver Biotherapeutics For Rare And Complex Conditions

Press Release . Partnerships

June 08, 2022

The Parker Institute For Cancer Immunotherapy And Resilience Announce Strategic Alliance To Develop Next-Generation Cancer Therapies

Press Release . Partnerships

June 06, 2022

Resilience Announces $625 Million Series D Financing To Expand Network, Bring Innovative Technologies To Biomanufacturing

Press Release

June 02, 2022

Resilience And MD Anderson Launch Joint Venture To Accelerate Development And Manufacturing Of Innovative Cell Therapies For Cancer

Press Release . Partnerships

February 15, 2022

Resilience Establishes Multi-Product Development And Manufacturing Collaboration With Takeda’s Plasma-Derived Therapies Business Unit

Press Release

February 09, 2022

Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million From U.S. Department Of Defense For Botulinum Neurotoxin Treatment

Press Release

December 02, 2021

Resilience Acquires SwiftScale Biologics, A Leader In Cell-Free Protein Synthesis Technology

Press Release

October 15, 2021

Resilience And Harvard University Announce Five-Year R&D Alliance To Incubate New Technologies, Launch Companies To Advance The Manufacture Of Complex Medicines

Press Release . Partnerships

October 12, 2021

Resilience Joins Forces With Children’s Hospital Of Philadelphia To Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies

Press Release

September 08, 2021

Resilience To Manufacture mRNA For Moderna’s COVID-19 Vaccine

Press Release

August 02, 2021

Meet The 24 Biotech Startups That Top VCs Say Are Poised To Take Off In The next 12 Months

In The News

July 28, 2021

Bluebird Bio And Resilience Announce Strategic Alliance To Develop Next Generation Cell Therapies

Press Release

May 18, 2021

Resilience Receives USD $164 Million Investment From The Government of Canada to Modernize and Expand Its Ontario Biomanufacturing Site, Improving Pandemic Preparedness

Press Release . Financing

April 12, 2021

Resilience Continues Expansion With Acquisition Of Biologics Manufacturing Company Ology Bioservices

Press Release

March 03, 2021

How An East Bay Site May Lead A Biotech Manufacturing Revolution

Press Release

March 02, 2021

With Stars Aligned And Cash In Reserve, Bob Nelsen’s Resilience Plans A Makeover At 2 New Facility Additions To Its Drug Manufacturing Upstart

Press Release

March 02, 2021

Resilience Expands North American Capacity With The Acquisition Of Two Premier Biologics Manufacturing Facilities

Press Release

February 16, 2021

Fireside Chat With Rahul Signhvi, CEO Of Resilience

Press Release

February 15, 2021

Resilience Bags Sanofi-Genzyme Plant In Boston

Press Release

February 11, 2021

Sanofi Prepares To Transfer Allston Plant To A New Company, But Not Its City Tax Breaks

Press Release

November 30, 2020

Raging At The Pandemic, A VC Raises $800M For A Company That Aims To Transform Biotech Manufacturing

In The News

November 23, 2020

Resilience Launches To Change The Future Of Medicine Through Manufacturing Innovation

Press Release